Physician

Jeff Regan Peterson, MD

According to 2025 Medicare claims, Jeff Peterson, MD (NPI: 1467491076) practices rheumatology in the Kahului-Wailuku, HI market, with the plurality of this provider's patient population coming from Maui, HI. This provider's primary affiliated billing organization is WESTERN WASHINGTON MEDICAL GROUP, INC PS (NPI: 1538606413; TIN: 911602128) and primary practice location at 98021-4418. Peterson is affiliated with the Aledade 99 Pacific Northwest MSSP Enhanced (ACO ID: A4999), participating under the MSSP model.

Peterson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 341 traditional Medicare patients, billed 80,255 HCPCS/CPT codes, and received $2,165,593 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,736 prescription claims across 406 beneficiaries totaling $1,416,972 in drug costs, led by Enbrel (Etanercept). DME data shows 23 claims. Open Payments data shows 272 records totaling $195,317. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $730,914 to $2,165,593. Similarly, Part D prescription costs have moved sharply higher in recent years, from $612,285 to $1,416,972. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	352	25,033	$730,914
2016	321	26,516	$838,110
2017	269	14,959	$725,154
2018	248	17,118	$864,468
2019	252	27,469	$1,020,447
2020	253	35,585	$1,175,032
2021	241	40,459	$920,260
2022	347	58,025	$1,311,510
2023	355	68,862	$1,685,919
2024	341	80,255	$2,165,593

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	225	2,408	$612,285
2016	223	2,316	$488,059
2017	239	2,172	$427,579
2018	197	2,211	$645,625
2019	219	2,230	$734,129
2020	309	2,469	$824,105
2021	244	2,442	$807,998
2022	358	3,070	$1,174,387
2023	377	3,012	$1,277,178
2024	406	2,736	$1,416,972

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	13	$39,309
2021	N/R	12	$41,110
2022	N/R	13	$44,989
2023	N/R	13	$45,658
2024	N/R	23	$46,077

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	61	84	$129
96413	Administration of chemotherapy into vein, 1 hour or less	89	496	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	234	465	$90
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	153	260	$12
J7050	Infusion, normal saline solution, 250 cc	81	483	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel	Etanercept	11	924	$242,973
Humira(Cf) Pen	Adalimumab	19	532	$194,413
Xeljanz Xr	Tofacitinib Citrate	31	930	$174,640
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	215	16,748	$9,668
Methotrexate	Methotrexate Sodium	308	22,437	$8,978

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	N	N/R	12	$42,451
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	11	$3,626

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	267	$145,159	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	5	$50,157	Eli Lilly and Company
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jeff Regan Peterson, MD?

Tedicare shows public-source Medicare data for Jeff Regan Peterson, MD (NPI 1467491076), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeff Regan Peterson, MD have ACO affiliation data?

Jeff Regan Peterson, MD is shown with ACO affiliation data for Aledade 99 Pacific Northwest MSSP Enhanced (MSSP, ACO ID A4999).

What billing organization is linked to Jeff Regan Peterson, MD?

Jeff Regan Peterson, MD is linked to WESTERN WASHINGTON MEDICAL GROUP, INC PS (billing NPI 1538606413) in the available physician profile data.

Does Jeff Regan Peterson, MD have Open Payments data?

Jeff Regan Peterson, MD has 272 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.